Drug Type Small molecule drug |
Synonyms AMG 319, AMG319 |
Target |
Action inhibitors |
Mechanism PI3Kδ inhibitors(Phosphatidylinositol 3 kinase delta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H16FN7 |
InChIKeyKWRYMZHCQIOOEB-LBPRGKRZSA-N |
CAS Registry1608125-21-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 1 | United States | 01 Apr 2011 | |
Diffuse Large B-Cell Lymphoma | Phase 1 | United States | 01 Apr 2011 | |
Low Grade B-Cell Non-Hodgkin's Lymphoma | Phase 1 | United States | 01 Apr 2011 | |
Mantle-Cell Lymphoma | Phase 1 | United States | 01 Apr 2011 | |
T-Cell Lymphoma | Phase 1 | United States | 01 Apr 2011 |